Tzu-Fei Wang
MD, MPH
Scientist, Inflammation and Chronic Disease
Ottawa Hospital Research Institute
Associate professor, Division of Hematology
Department of Medicine
Bio
Tzu-Fei Wang, MD, MPH is a hematologist and an associate professor in the Division of Hematology, Department of Medicine at the University of Ottawa and the Ottawa Hospital and a Scientist at the Ottawa Hospital Research Institute. Her main areas of clinical and research interest include clinical research for the optimal prevention and treatment strategies for patients with cancer-associated thrombosis, drug-drug interactions with anticoagulants, and obesity-related thromboembolism. She holds a Tier 2 Clinical Research Chair in Cancer and Thromboembolism from the University of Ottawa. She has received research funding from the International Society on Thrombosis and Haemostasis (ISTH), the Canadian Institutes of Health Research (CIHR), The Ottawa Hospital Academic Medical Organization (TOHAMO), and the International Network of VENous Thromboembolism Clinical Research Networks (INVENT). She is currently the Chair of the ISTH (International Society on Thrombosis and Haemostasis) Live Courses Subcommittee of the Education Committee. She was a co-chair of the Hemostasis and Malignancy Subcommittee of the International Society on Thrombosis and Haemostasis from 2018 to 2022.
Research Goals and Interests
News
Publications
A Multicenter Prospective Cohort Study on the Use of Weight‐Adjusted Dalteparin in Patients Over 90 kg With Acute Cancer‐Associated Venous Thromboembolism—The WAVe Study
2026-01-01 Go to publicationDerivation and External Validation of a Venous Thromboembolism Risk Prediction Model in Asparaginase-Treated ALL
2025-10-30 Go to publicationImpact of clonal hematopoiesis of indeterminate potential on arterial atherothrombosis and venous thromboembolism: Protocol for a systematic review and meta-analysis
2025-07-16 Go to publicationTo anticoagulate or not to anticoagulate—that is the question in patients with fall risks
2025-07-01 Go to publicationEfficacy and safety of extended duration postoperative thromboprophylaxis with low molecular weight heparin among subgroups of patients undergoing surgical resection of colorectal cancer: A post-hoc analysis of the PERIOP-01 trial
2025-05-01 Go to publication